Biopsy Devices Market Overview :
Global Biopsy Devices Market is estimated to reach $2,894 million by 2025; growing at a CAGR of 6.2% from 2017 to 2025. A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination to determine the presence of diseases. A biopsy can be used to investigate the abnormalities which can be functional, such as kidney and liver problems or structural, such as swelling in a particular organ. Biopsy of any cell or organ is to diagnose the abnormalities as benign or malignant. There are two main types of biopsies, needle and surgical biopsy.
Increasing number of incidences of cancer such as breast, prostate and lung is stimulating the growth of world biopsy market. Moreover, increasing demand for minimal invasion surgeries, rapid technological advancements and increasing awareness for diagnosis is also expected to elevate the market. However, high cost of biopsy devices and stringent regulations and standards for the use of biopsy and increasing complaints of breast cancer screening procedures are impeding the growth of the market. Moreover, increasing public awareness about chronic diseases in developing countries and need for disease screening for their early diagnosis and treatment provides opportunity for the growth of the market.
The market is segmented on the basis of device type, imaging technology, application, end-user and geography. Based on device type, the market is segmented into breast, gastrointestinal, bronchial, gynaecological, robotic, soft tissue, and other device types. CT scan, ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, and other imaging technologies are the bifurcations of imaging technology. By application, the market is segregated into breast biopsy, lung, prostate, liver, gastrointestinal, kidney, gynaecological, and other applications. Furthermore, hospital, and diagnostic centers are covered under end-user segment.
Based on geography, the global biopsy devices market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexica, whereas Europe consists of UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.
Some of the major companies in global biopsy devices market include Boston Scientific Corporation, Carefusion, Becton, Dickinson and Company, Olympus Corporation, Devicor Medical Products Inc., B. Braun Melsungen AG, FUJIFILM Holdings Corporation, Angiotech, Cardinal Health Inc., and INRAD, Inc., among others.
The key takeaways from the report
- The report will provide detailed analysis of Global Biopsy devices market with respect to major segments such as device type, imaging technology, application and end user of the market.
- The report will include the qualitative and quantitative analysis with market estimation over 2016 – 2025 and compound annual growth rate (CAGR) between 2017 and 2025
- Comprehensive analysis of market dynamics including factors and opportunities has been included in the report
- An exhaustive regional analysis of Global Biopsy devices market has been covered under the scope of the report
- Profile of key players of the Global Biopsy devices market, which include key financials, product & services and new developments
Scope of Global Biopsy Devices Market
Device Type Segments
- Soft tissue
- Other Device Types
- CT scan
- Ultrasound-Guided Biopsy
- MRI-guided biopsy
- Stereotactic-Guided Biopsy
- Other Imaging Technologies
- Breast Biopsy
- Other Applications
- Diagnostics Centers
- North America
- Rest of Europe
- Rest of Asia-Pacific
- South America
- Middle East